JPMorgan analyst Tessa Romero resumes coverage on WAVE Life Sciences (NASDAQ: WVE) with a Neutral rating.The analyst comments: “Wave leverages ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage